The future of immunotherapy for diffuse large B‐cell lymphoma
Sign Up to like & getrecommendations! Published in 2024 at "International Journal of Cancer"
DOI: 10.1002/ijc.35156
Abstract: With the introduction of anti‐CD19 chimeric antigen receptor (CAR) T‐cell (CAR T) therapies, bispecific CD3/CD20 antibodies and anti‐CD19 antibodies, immunotherapy continues to transform the treatment of diffuse large B‐cell lymphoma (DLBCL). A number of novel… read more here.
Keywords: future immunotherapy; cell lymphoma; cell; diffuse large ... See more keywords
The Future of Immunotherapy in the Treatment of Cancer.
Sign Up to like & getrecommendations! Published in 2019 at "Seminars in oncology nursing"
DOI: 10.1016/j.soncn.2019.08.013
Abstract: OBJECTIVES To discuss future direction and present an overview of the evolution of immunotherapy long-term toxicity issues, financial toxicity, and new emerging survivorship considerations. DATA SOURCES Peer-reviewed manuscripts, Web sites. CONCLUSION Cancer treatments involving immunotherapy… read more here.
Keywords: immunotherapy; immunotherapy treatment; future immunotherapy; toxicity ... See more keywords
The Future of Immunotherapy: A 20-Year Perspective
Sign Up to like & getrecommendations! Published in 2017 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2017.01668
Abstract: Immunotherapy is the field of immunology that aims to identify treatments for diseases through induction, enhancement or suppression of an immune response. Immunotherapies designed to instigate or enhance an immune response are considered “activating immunotherapies”… read more here.
Keywords: year perspective; immunotherapy year; immune response; future immunotherapy ... See more keywords